Genic Co

Genic Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Genic Co (123330.KQ) as of Nov 2, 2026 is 26.49 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 15.79 % — a change of 67.80% (higher).

EBIT/Assets

26.49 %

YoY

67.80%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Genic Co is 2025 26.49 % . Operating Income to Assets Ratio (EBIT/Assets) of Genic Co was 2024 15.79 % . It decreases by 67.80% higher compared to the previous year.

The Genic Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-15.56 KRW
Jan 1, 2019
-18.66 KRW
Jan 1, 2020
1.38 KRW
Jan 1, 2021
-7.80 KRW
Jan 1, 2022
-11.62 KRW
Jan 1, 2023
-17.23 KRW
Jan 1, 2024
15.79 KRW
Jan 1, 2025
26.49 KRW
The Genic Co EBIT/Assets history
YEAREBIT/AssetsYoY
26.49 %+67.80%
15.79 %-191.65%
-17.23 %+48.21%
-11.62 %+48.96%
-7.80 %-665.37%
1.38 %-107.39%
-18.66 %+19.93%
-15.56 %+75.41%
-8.87 %-268.12%
5.28 %+49.62%
3.53 %+39.18%
2.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genic Co Stock analysis

What does Genic Co do? Genic Co., Ltd. manufactures and sells cosmetics under brands such as Cel-Derma, Lasante, Puretree, and others. The company offers gel masks, essence masks, gel eye patches, self-heating masks, cleansers, basics, skin care products, makeup, hair care, perfumes, men cosmetics, body care, and manicures. It distributes its products domestically and internationally, targeting consumers seeking skincare, makeup, and personal care solutions through its branded product lines. The firm's revenue comes from selling its branded cosmetic products globally, with domestic and overseas markets as key sales channels. Customers purchase products under the Cel-Derma, Lasante, Puretree, and other brand names for skincare, makeup, hair care, and body care needs. Genic Co., Ltd. focuses on skincare and personal care segments, offering a wide range of products including masks, cleansers, makeup, and perfumes under its established brands. Its product portfolio serves both domestic and international consumer markets through direct sales and distribution networks. Genic Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genic Co stock

Operating Income to Assets Ratio (EBIT/Assets) of Genic Co is 26.49 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Genic Co changed from 15.79 % to 26.49 %, representing a 67.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Genic Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Genic Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Genic Co

All Key Metrics — Genic Co